abiraterone acetate
NDC 68462-135, abiraterone acetate, tablet, from Glenmark Pharmaceuticals Inc., USA.
- Product NDC
- 68462-135
- Status
- Listed
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209227
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68462-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68462-135-08 | 68462013508 | 120 TABLET in 1 BOTTLE (68462-135-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ba32c453-a231-452a-a6d9-b3e57afb2e75NADAC price for package 68462013508
GET /v1/drugs/nadac/68462013508
Use it
Look up 68462-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68462-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68462-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.